Cargando…
Prognostic impact of syndecan-1 expression in invasive ductal breast carcinomas
Carcinoma cells lack syndecan-1 expression when they are transiting from an epithelial to a less-differentiated mesenchymal phenotype (epithelial–mesenchymal transition, EMT). Furthermore, a shift of syndecan-1 expression from malignant epithelial cells to reactive stromal cells has also been observ...
Autores principales: | Loussouarn, D, Campion, L, Sagan, C, Frenel, J-S, Dravet, F, Classe, J-M, Pioud-Martigny, R, Berton-Rigaud, D, Bourbouloux, E, Mosnier, J-F, Bataille, F-R, Campone, M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2441962/ https://www.ncbi.nlm.nih.gov/pubmed/18542065 http://dx.doi.org/10.1038/sj.bjc.6604400 |
Ejemplares similares
-
Validation of UBE2C protein as a prognostic marker in node-positive breast cancer
por: Loussouarn, D, et al.
Publicado: (2009) -
Co-expression of KLK6 and KLK10 as prognostic factors for survival in pancreatic ductal adenocarcinoma
por: Rückert, F, et al.
Publicado: (2008) -
hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma
por: Lastraioli, E, et al.
Publicado: (2015) -
The relationship between tumour budding, the tumour microenvironment and survival in patients with invasive ductal breast cancer
por: Gujam, F J A, et al.
Publicado: (2015) -
Immunological subtypes in breast cancer are prognostic for invasive ductal but not for invasive lobular breast carcinoma
por: Engels, C C, et al.
Publicado: (2014)